PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1204
https://www.valueinhealthjournal.com/article/S1098-3015(12)02917-8/fulltext
Section Title :
Cancer
Section Order :
704
First Page :
A410
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02917-8&doi=10.1016/j.jval.2012.08.1204